Liquiritin and Liquiritigenin Induce Melanogenesis via Enhancement of p38 and PKA Signaling Pathways
Abstract
Share and Cite
Uto, T.; Ohta, T.; Yamashita, A.; Fujii, S.; Shoyama, Y. Liquiritin and Liquiritigenin Induce Melanogenesis via Enhancement of p38 and PKA Signaling Pathways. Medicines 2019, 6, 68. https://doi.org/10.3390/medicines6020068
Uto T, Ohta T, Yamashita A, Fujii S, Shoyama Y. Liquiritin and Liquiritigenin Induce Melanogenesis via Enhancement of p38 and PKA Signaling Pathways. Medicines. 2019; 6(2):68. https://doi.org/10.3390/medicines6020068
Chicago/Turabian StyleUto, Takuhiro, Tomoe Ohta, Akihisa Yamashita, Shunsuke Fujii, and Yukihiro Shoyama. 2019. "Liquiritin and Liquiritigenin Induce Melanogenesis via Enhancement of p38 and PKA Signaling Pathways" Medicines 6, no. 2: 68. https://doi.org/10.3390/medicines6020068
APA StyleUto, T., Ohta, T., Yamashita, A., Fujii, S., & Shoyama, Y. (2019). Liquiritin and Liquiritigenin Induce Melanogenesis via Enhancement of p38 and PKA Signaling Pathways. Medicines, 6(2), 68. https://doi.org/10.3390/medicines6020068
